Public Employees Retirement Association of Colorado boosted its position in Amsurg Corp. (NASDAQ:AMSG) by 0.5% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 362,238 shares of the company’s stock after buying an additional 1,727 shares during the period. Public Employees Retirement Association of Colorado owned 0.67% of Amsurg Corp. worth $28,088,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Smith Asset Management Group LP increased its position in shares of Amsurg Corp. by 8,500.0% in the second quarter. Smith Asset Management Group LP now owns 1,720 shares of the company’s stock valued at $133,000 after buying an additional 1,700 shares during the period. Invictus RG increased its position in shares of Amsurg Corp. by 824.3% in the first quarter. Invictus RG now owns 1,904 shares of the company’s stock valued at $142,000 after buying an additional 1,698 shares during the period. Checchi Capital Advisers LLC bought a new position in shares of Amsurg Corp. during the second quarter valued at $157,000. Oakbrook Investments LLC bought a new position in shares of Amsurg Corp. during the second quarter valued at $209,000. Finally, Mount Lucas Management LP increased its position in shares of Amsurg Corp. by 10.3% in the first quarter. Mount Lucas Management LP now owns 3,483 shares of the company’s stock valued at $260,000 after buying an additional 326 shares during the period. Hedge funds and other institutional investors own 98.43% of the company’s stock.

Institutional Ownership by Quarter for Amsurg Corp. (NASDAQ:AMSG)

Shares of Amsurg Corp. (NASDAQ:AMSG) traded up 1.98% during trading on Monday, reaching $67.34. The company had a trading volume of 461,033 shares. The stock has a market capitalization of $3.62 billion, a PE ratio of 19.98 and a beta of 0.68. Amsurg Corp. has a 12 month low of $58.37 and a 12 month high of $87.29. The stock’s 50-day moving average price is $65.63 and its 200-day moving average price is $73.31.

Amsurg Corp. (NASDAQ:AMSG) last announced its quarterly earnings data on Tuesday, August 2nd. The company reported $1.10 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.08 by $0.02. Amsurg Corp. had a return on equity of 8.20% and a net margin of 6.53%. The firm had revenue of $758.50 million for the quarter, compared to analysts’ expectations of $769.88 million. During the same quarter in the prior year, the firm posted $0.97 earnings per share. Amsurg Corp.’s revenue for the quarter was up 21.5% compared to the same quarter last year. Equities analysts forecast that Amsurg Corp. will post $4.33 earnings per share for the current fiscal year.

AMSG has been the topic of several analyst reports. Bank of America Corp. upgraded Amsurg Corp. from a “neutral” rating to a “buy” rating and set a $104.00 target price on the stock in a research note on Thursday, June 16th. Jefferies Group reiterated a “buy” rating on shares of Amsurg Corp. in a research note on Sunday, July 3rd. Citigroup Inc. initiated coverage on Amsurg Corp. in a research note on Monday, September 26th. They issued a “buy” rating and a $79.00 target price on the stock. Wells Fargo & Co. initiated coverage on Amsurg Corp. in a research note on Tuesday, June 14th. They issued a “market perform” rating on the stock. Finally, KeyCorp reissued a “positive” rating and issued a $87.00 price target on shares of Amsurg Corp. in a report on Tuesday, October 4th. Three equities research analysts have rated the stock with a hold rating and ten have issued a buy rating to the company’s stock. Amsurg Corp. currently has a consensus rating of “Buy” and a consensus price target of $92.09.

In other Amsurg Corp. news, insider Robert Jon Coward sold 7,500 shares of the company’s stock in a transaction that occurred on Friday, August 26th. The stock was sold at an average price of $63.65, for a total transaction of $477,375.00. Following the sale, the insider now owns 97,507 shares in the company, valued at $6,206,320.55. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Company insiders own 2.30% of the company’s stock.

About Amsurg Corp.

AmSurg Corp. is a surgical center and physician services company. The Company is an owner and operator of ambulatory surgery centers (ASCs) in the United States. The Company is also a provider of outsourced physician services in the areas of anesthesiology, children’s services, emergency medicine and radiology.

5 Day Chart for NASDAQ:AMSG

Receive News & Stock Ratings for Amsurg Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amsurg Corp. and related stocks with our FREE daily email newsletter.